| Literature DB >> 22666490 |
Yazan Ismail1, Vikneswari Mahendran, Sophie Octavia, Andrew S Day, Stephen M Riordan, Michael C Grimm, Ruiting Lan, Daniel Lemberg, Thi Anh Tuyet Tran, Li Zhang.
Abstract
BACKGROUND: Campylobacter concisus, a bacterium colonizing the human oral cavity, has been shown to be associated with inflammatory bowel disease (IBD). This study investigated if patients with IBD are colonized with specific oral C. concisus strains that have potential to cause enteric diseases.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22666490 PMCID: PMC3364211 DOI: 10.1371/journal.pone.0038217
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sequence types (ST) and allelic profiles of C. concisus isolated from patients with IBD and controls.
| Isolate ID | Total No. of isolate | ST |
|
|
|
|
|
|
|
| 16 |
| 8 | 7 | 4 | 6 | 1 | 1 |
|
| 2 |
| 2 | 5 | 3 | 7 | 7 | 5 |
|
| 1 |
| 8 | 5 | 4 | 6 | 1 | 2 |
|
| 1 |
| 1 | 7 | 4 | 6 | 1 | 1 |
|
| 1 |
| 8 | 7 | 4 | 6 | 1 | 2 |
|
| 1 |
| 8 | 4 | 2 | 8 | 4 | 3 |
|
| 2 |
| 7 | 8 | 5 | 5 | 8 | 7 |
|
| 2 |
| 6 | 6 | 6 | 4 | 9 | 8 |
|
| 1 |
| 7 | 8 | 5 | 5 | 8 | 8 |
|
| 1 |
| 6 | 8 | 6 | 4 | 9 | 8 |
|
| 1 |
| 6 | 6 | 6 | 4 | 9 | 7 |
|
| 20 |
| 5 | 1 | 1 | 1 | 3 | 4 |
|
| 1 |
| 5 | 1 | 1 | 1 | 2 | 4 |
|
| 1 |
| 4 | 2 | 8 | 3 | 6 | 4 |
|
| 9 |
| 3 | 3 | 7 | 2 | 5 | 6 |
|
| 1 |
| 10 | 18 | 16 | 9 | 12 | 10 |
|
| 1 |
| 11 | 14 | 14 | 14 | 10 | 17 |
|
| 1 |
| 12 | 16 | 1 | 3 | 15 | 4 |
|
| 1 |
| 13 | 9 | 15 | 13 | 19 | 9 |
|
| 1 |
| 14 | 12 | 9 | 16 | 14 | 16 |
|
| 1 |
| 15 | 17 | 13 | 12 | 18 | 15 |
|
| 1 |
| 16 | 15 | 11 | 10 | 11 | 11 |
|
| 1 |
| 17 | 13 | 12 | 11 | 17 | 13 |
|
| 1 |
| 18 | 10 | 16 | 17 | 13 | 12 |
|
| 1 |
| 9 | 11 | 10 | 15 | 16 | 14 |
|
|
| 19 | 19 | 17 | 18 | 20 | 18 |
Recombinant or mutational variants of the patient’s own oral C. concisus strains.
This strain, which was isolated from a patient with CD, had asd gene identical to the patient’s own oral C. concisus isolates.
Figure 1Neighbour-Joining tree based on the sequences of six housekeeping genes (asd, aspA, atpA, glnA, pgi and tkt) illustrating the phylogenetic relationships of oral and enteric Campylobacter concisus isolates analysed in this study.
Isolates from patients with IBD are coloured red. Isolates from a healthy control are coloured blue. Clusters are indicated in roman numerals. Campylobacter curvus is used as an outgroup. Alongside the tree on the right are the MLST sequence types (ST) and protein profiles. Campylobacter concisus strain 13826 is the whole genome sequenced strain (Accession No.: CP000792.1).
Enteric invasive C. concisus (EICC) oral isolates detected in patients with IBD.
| Individual ID and Clinical condition | Sample source | EICC isolates identified | Invasion Index |
|
| Saliva | P1CDO3 P1CDO18 | 2.0±0.9 1.5±0.2 |
|
| Intestinal biopsy | P1CDB1 (UNSWCD) | 1.3±0.2 |
|
| Saliva | P2CDO1 P2CDO2 P2CDO3 P2CDO4 P2CDO5 P2CDO6 P2CDO7 | 9.5±0.9 6.5±1.4 11.1±3.0 6.4±1.0 5±0.9 12.3±3.2 11.2±2.8 |
|
| Saliva | P5CDO1 | 4.0±1.1 |
|
| Saliva | P8UCO1 | 3.0±0.9 |
The invasion index was the average of triplicate experiments
Positive control strain used in this study.
Figure 2Representative whole cell protein profiles of oral and enteric C. concisus isolates obtained from patients with IBD and healthy controls.
Arrows indicate protein bands that have been sequenced for protein identification. M: molecular weight Marker. Each lane was labelled as Protein profile (Isolate ID).
Distinctive proteins identified from the most abundantly expressed protein band# of an oral EICC isolate and the corresponding band of a non-EICC oral C. concisus isolate obtained from patient 1.
| EICC isolate (P1CDO3) | Non-EICC isolate (P1CDO2) |
| General glycosylation pathway protein | 3-isopropylmalate dehydratase large subunit Glutamate dehydrogenase Signal recognition particle protein Threonine dehydratase |
Protein bands were shown in Figure 3.
Proteins related to bacterial virulence.
Figure 3Electron Microscopic image of an oral EICC isolate, an oral non-EICC isolate and an enteric EICC isolate.
All isolates were cultured from Patient No. 1.
C. concisus isolates used in this study.
| Isolate ID | Number of isolates | Sample source | Individual ID and diagnosis |
|
| 21 | Saliva | Patient No. 1, CD |
|
| 1 | Intestinal biopsies | Patient No. 1, CD |
|
| 7 | Saliva | Patient No. 2, CD |
|
| 10 | Saliva | Patient No. 3, UC |
|
| 10 | Intestinal biopsies | Patient No. 3, UC |
|
| 2 | Luminal-washout fluid | Patient No. 3, UC |
|
| 1 | Saliva | Patient No. 4, CD |
|
| 1 | Saliva | Patient No. 5, UC |
|
| 1 | Saliva | Patient No. 6, CD |
|
| 1 | Saliva | Patient No. 7, UC |
|
| 1 | Saliva | Patient No. 8, UC |
|
| 9 | Saliva | Healthy individual No. 1 |
|
| 1 | Saliva | Healthy individual No. 2 |
|
| 1 | Saliva | Healthy individual No. 3 |
|
| 1 | Saliva | Healthy individual No. 4 |
|
| 1 | Saliva | Healthy individual No. 5 |
|
| 1 | Saliva | Healthy individual No. 6 |
A total of 70 C. concisus isolates were examined in this study.
C. concisus isolated from intestinal biopsies and luminal-washout fluid was referred as enteric C. concisus and C. concisus isolated from saliva was referred as oral C. concisus.
Clinical information of patients included in this study.
| Patient ID-Sex- Age at diagnosis | Diagnosis and disease activity at the timeof sample collection | Montreal classification |
|
| CD, new case, active | L2, L4 |
|
| CD, relapse, active | L3, L4 |
|
| UC, new case, active | Extensive E3/S1 |
|
| CD, remission | L3,L4 |
|
| CD, remission | L2,L4 |
|
| CD, remission | L3, L4 |
|
| UC, new case, active | Left sided E2/S2 |
|
| UC, remission | Left sided E2/S1 |
C. concisus strains were previously isolated from biopsies of patients No. 1 and No. 3 [9], [11]. The intestinal biopsies collected from patients No. 1 and No. 3 were from caecum and descending colon respectively, sampled from areas next to inflamed mucosa. C. concisus was detected in intestinal biopsies collected from patients No. 2 and No. 7 by PCR [11]. No intestinal biopsies were available from patients in remission.
Patients No. 2, No. 5, No. 6 and No. 8 were being treated with anti-inflammatory drugs (infliximab, aminosalicylates, methotrexate or azathioprine) at the time of saliva collection. Patient No. 4 had ileocolonic resection and antibiotics treatment (metronidazone and ciprofloxacin) two years ago. None of the patients were receiving antibiotics treatment at the time of sample collection for this study.
PCR primers used for amplification of MLST genes in this study.
| Gene | ′–′Forward sequence (53) | ′–Reverse sequence (53) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PCR primers were designed based on the whole genome sequenced C. concisus strain 13826 (Accession No: CP000792.1).